[Asia Economy Reporter Geum Bo-ryeong] Eutilex announced on the 21st that it received notification from the Ministry of Food and Drug Safety to resume the domestic Phase 1/2 clinical trial of the anticancer drug 'AppB&T Cell'.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
